Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-09

FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approved Padagis Israel Pharmaceuticals' generic clindamycin phosphate and benzoyl peroxide topical product for acne vulgaris under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin Phosphate and Benzoyl Peroxide (clindamycin phosphate and benzoyl peroxide)

Snippet

ORIG AP for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (CLINDAMYCIN PHOSPHATE, BENZOYL PEROXIDE)